(NP (NP (NP (JJ Single) (NN strand) (NN conformation) (NN polymorphism) (NN analysis)) (PP (IN of) (NP (NP (NN androgen) (NN receptor) (NN gene) (NNS mutations)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN androgen) (NN insensitivity) (NNS syndromes))))))) (: :)) (NP (NP (NN application)) (PP (IN for) (NP-COOD (NP (NN diagnosis)) (, ,) (NP (JJ genetic) (NN counseling)) (, ,) (CC and) (NP (NN therapy)))) (. .)))
(S (NP-SBJ (JJ Recent) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ-1 (NP (NNS mutations)) (PP (IN in) (NP (DT the) (NN androgen) (NN receptor) (NN gene)))) (VP (VBP are) (VP (VBN associated) (NP (-NONE- *-1)) (PP (IN with) (NP (NP (NN androgen) (NN insensitivity) (NNS syndromes)) (, ,) (NP (NP (DT a) (JJ heterogeneous) (NN group)) (PP (IN of) (NP (NP (JJ related) (NNS disorders)) (VP (VBG involving) (NP (NP (JJ defective) (JJ sexual) (NN differentiation)) (PP (IN in) (NP (JJ karyotypic) (NNS males))))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP-SBJ (PRP we)) (VP (VBP address) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (JJ rapid) (JJ mutational) (NN analysis)) (PP (IN of) (NP (DT the) (NN androgen) (NN receptor) (NN gene))) (PP (IN for) (NP (NP-COOD (NP (JJ initial) (NN diagnosis)) (, ,) (NP (JJ genetic) (NN counseling)) (, ,) (CC and) (NP (JJ molecular) (NN subclassification))) (PP (IN of) (NP-COOD (NP (VBN affected) (NNS patients)) (CC and) (NP (PRP$ their) (NNS families)))))))))) (. .))
(S (NP-SBJ-2 (NP (NN DNA)) (PP (IN from) (NP (NP (JJ peripheral) (NN blood) (NNS leukocytes)) (PP (IN of) (NP (NP (CD six) (NNS patients)) (PP (IN from) (NP (CD five) (NNS families))) (PP (IN with) (NP (NP (JJ various) (NNS degrees)) (PP (IN of) (NP (NN androgen) (NN insensitivity)))))))))) (VP (VBD was) (VP (VBN studied) (NP (-NONE- *-2)))) (. .))
(S (NP-SBJ-3 (NP (NNS Exons) (NP-COOD (NP (CD 2)) (TO to) (NP (CD 8)))) (PP (IN of) (NP (DT the) (NN androgen) (NN receptor) (NN gene)))) (VP (VBD were) (VP (VBN analyzed) (NP (-NONE- *-3)) (S (NP-SBJ (-NONE- *)) (VP (VBG using) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP-COOD (NP (JJ single) (NN strand) (NN conformation) (NN polymorphism) (NN analysis)) (CC and) (NP (JJ direct) (NN DNA) (NN sequencing))))))))) (. .))
(S (NP-SBJ-4 (JJ Female) (NN family) (NNS members)) (VP (VBD were) (VP (ADVP (RB also)) (VBN studied) (NP (-NONE- *-4)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB identify) (NP (NN heterozygote) (NNS carriers))))))) (. .))
(S-COOD (S (NP-SBJ-5 (NP (NN Point) (NNS mutations)) (PP (IN in) (NP (DT the) (NN AR) (NN gene)))) (VP (VBD were) (VP (VBN identified) (NP (-NONE- *-5)) (PP (IN in) (NP (QP (DT all) (CD six)) (NNS patients)))))) (, ,) (CC and) (S (NP-SBJ (DT all) (NNS mutations)) (VP (VBD caused) (NP (NN amino) (NN acid) (NNS substitutions)))) (. .))
(S (NP-SBJ (NP (CD One) (NN patient)) (PP (IN with) (NP (JJ incomplete) (NN androgen) (NN insensitivity)))) (VP (VBD was) (NP-PRD (NP (DT a) (NN mosaic)) (PP (IN for) (NP (DT the) (NN mutation))))) (. .))
(S (NP-SBJ-COOD (NP (NP (CD Four)) (PP (IN of) (NP (DT the) (CD five) (NNS mothers)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT a) (JJ young) (NN sister)) (PP (IN of) (NP (CD one) (NN patient)))) (, ,)) (VP (VBD were) (NP-PRD (NP (NNS carriers)) (PP (IN of) (NP (NP (DT the) (NN mutation)) (ADJP (JJ present) (PP (IN in) (NP (DT the) (VBN affected) (NN child)))))))) (. .))
(S (NP-SBJ (PRP$ Our) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ-100 (JJ new) (NNS mutations)) (VP (MD may) (VP (VB occur) (PP (IN in) (NP (DT the) (NN androgen) (NN receptor) (NN gene))) (S (NP-SBJ (-NONE- *-100)) (VP (VBG leading) (PP (TO to) (NP (JJ sporadic) (NN androgen) (NN insensitivity) (NN syndrome)))))))))) (. .))
(S (NP-SBJ (NP (JJ Molecular) (JJ genetic) (NN characterization)) (PP (IN of) (NP (DT the) (JJ variant) (NN allele)))) (VP-COOD (VP (MD can) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (JJ primary) (NN tool)) (PP (IN for) (NP-COOD (NP (NN diagnosis)) (CC and) (NP (JJ subsequent) (NN therapy)))))))) (, ,) (CC and) (VP (MD can) (VP (VB provide) (NP (NP (DT a) (NN basis)) (PP (IN for) (S (NP-SBJ (-NONE- *)) (VP (VBG distinguishing) (NP (NP (JJ heterozygous) (NNS carriers)) (PP (IN in) (NP (JJ familial) (NN androgen) (NN resistance))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN identification)) (PP (IN of) (NP (NNS carriers)))) (VP (VBZ is) (PP-PRD (IN of) (NP (JJ substantial) (JJ clinical) (NN importance))) (PP (IN for) (NP (JJ genetic) (NN counseling)))) (. .))
